Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Acute Blood Loss Anemia: full-pipeline trial registry
2 of 3 indexed Acute Blood Loss Anemia trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Acute Blood Loss Anemia: 3 US clinical trials tracked, 2 recruiting.
Acute Blood Loss Anemia is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Henry Ford Health System, running 1 of these trials.
Enrollment posture brief
Registry condition acute-blood-loss-anemia
OPEN 2 | RECR 67% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Acute Blood Loss Anemia lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Acute Blood Loss Anemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Acute Blood Loss Anemia is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
University of Florida
NCT06606119
Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma
Oregon Health and Science University
NCT05292001
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty
Henry Ford Health System
NCT01370460
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Acute Blood Loss Anemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Acute Blood Loss Anemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Acute Blood Loss Anemia page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Acute Blood Loss Anemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Henry Ford Health System sponsors the most Acute Blood Loss Anemia trials on record, review their full trial history before evaluating a specific study. See Henry Ford Health System's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Blood Loss Anemia condition card totals 3 registered trials; most-linked intervention Iron-Dextran Complex Injection [InFed]; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.